Medtronic ROE 2006-2019 | MDT

Current and historical return on equity (ROE) values for Medtronic (MDT) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Medtronic ROE for the three months ending January 31, 2019 was 13.85%.
Medtronic ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-01-31 $4.92B $49.94B 9.80%
2018-10-31 $2.26B $49.71B 4.49%
2018-07-31 $3.16B $50.33B 6.23%
2018-04-30 $3.10B $50.82B 6.10%
2018-01-31 $2.81B $50.34B 5.53%
2017-10-31 $5.02B $51.58B 9.93%
2017-07-31 $4.12B $50.79B 8.19%
2017-04-30 $4.03B $50.33B 8.02%
2017-01-31 $3.97B $49.49B 7.83%
2016-10-31 $4.24B $50.29B 8.32%
2016-07-31 $3.65B $50.89B 7.08%
2016-04-30 $3.54B $52.06B 6.81%
2016-01-31 $2.43B $50.82B 4.66%
2015-10-31 $2.32B $52.27B 5.19%
2015-07-31 $2.62B $52.81B 7.21%
2015-04-30 $2.68B $53.23B 9.55%
2015-01-31 $3.12B $20.17B 15.96%
2014-10-31 $2.91B $19.44B 15.02%
2014-07-31 $2.98B $19.25B 15.54%
2014-04-30 $3.07B $19.44B 16.12%
2014-01-31 $3.59B $19.35B 19.05%
2013-10-31 $3.81B $18.74B 20.67%
2013-07-31 $3.56B $18.52B 19.70%
2013-04-30 $3.47B $18.67B 19.55%
2013-01-31 $3.49B $17.84B 20.11%
2012-10-31 $3.44B $17.18B 20.00%
2012-07-31 $3.66B $17.26B 21.44%
2012-04-30 $3.62B $17.11B 21.48%
2012-01-31 $3.40B $17.17B 20.56%
2011-10-31 $3.39B $16.74B 21.07%
2011-07-31 $3.09B $16.34B 19.76%
2011-04-30 $3.10B $15.97B 20.38%
2011-01-31 $3.28B $15.36B 22.05%
2010-10-31 $3.18B $14.83B 21.80%
2010-07-31 $3.48B $14.60B 24.38%
2010-04-30 $3.10B $14.63B 22.25%
2010-01-31 $2.25B $14.32B 16.56%
2009-10-31 $2.11B $13.61B 15.95%
2009-07-31 $1.79B $13.14B 13.78%
2009-04-30 $2.07B $13.18B 16.20%
2009-01-31 $2.69B $13.06B 21.74%
2008-10-31 $2.07B $12.62B 17.46%
2008-07-31 $2.19B $12.24B 18.92%
2008-04-30 $2.14B $11.54B 18.95%
2008-01-31 $2.23B $10.97B 20.02%
2007-10-31 $2.86B $11.48B 25.69%
2007-07-31 $2.88B $11.14B 26.54%
2007-04-30 $2.80B $10.98B 26.60%
2007-01-31 $2.73B $10.98B 26.93%
2006-10-31 $2.69B $10.28B 26.05%
2006-07-31 $2.83B $9.90B 26.81%
2006-04-30 $2.55B $9.38B 23.78%
2006-01-31 $2.00B $11.74B 18.25%
2005-10-31 $1.88B $11.13B 17.71%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $121.227B $29.953B
Medtronic Public Limited Company, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $136.952B 27.07
Stryker (SYK) United States $72.547B 26.60
Boston Scientific (BSX) United States $51.696B 25.20
Baxter (BAX) United States $39.588B 25.33
Zimmer Biomet Holdings (ZBH) United States $25.898B 16.58
Smith & Nephew SNATS (SNN) United Kingdom $17.446B 0.00
Canopy Growth (CGC) Canada $14.852B 0.00
ResMed (RMD) United States $14.350B 27.21
Bio-Rad Laboratories (BIO) United States $9.156B 52.24
Aurora Cannabis (ACB) Canada $9.141B 64.50
Hill-Rom Holdings (HRC) United States $6.962B 21.53
Perrigo (PRGO) Ireland $6.420B 10.41
Insulet (PODD) United States $5.800B 1956.80
GW Pharmaceuticals (GWPH) United Kingdom $5.092B 0.00
ICU Medical (ICUI) United States $4.698B 29.24
Haemonetics (HAE) United States $4.311B 38.24
Hutchison China MediTech (HCM) China $3.810B 0.00
Agios Pharmaceuticals (AGIO) United States $3.637B 0.00
Neogen (NEOG) United States $3.108B 47.74
NuVasive (NUVA) United States $2.892B 25.23
Quidel (QDEL) United States $2.514B 22.68
Aphria (APHA) $2.385B 105.89
National Vision Holdings (EYE) United States $2.274B 44.72
Cardiovascular Systems (CSII) United States $1.346B 966.50
Phibro Animal Health (PAHC) United States $1.283B 18.45
VAREX IMAGING (VREX) United States $1.275B 24.96
AtriCure (ATRC) United States $1.081B 0.00
MacroGenics (MGNX) United States $0.926B 0.00
Lantheus Holdings (LNTH) United States $0.911B 24.60
Cerus (CERS) United States $0.844B 0.00
PetIQ (PETQ) United States $0.831B 23.77
Omeros (OMER) United States $0.828B 0.00
NanoString Technologies (NSTG) United States $0.729B 0.00
Meridian Bioscience (VIVO) United States $0.715B 21.30
OraSure Technologies (OSUR) United States $0.664B 29.11
Eagle Pharmaceuticals (EGRX) United States $0.657B 22.35
Evolus (EOLS) United States $0.655B 0.00
TG Therapeutics (TGTX) United States $0.601B 0.00
LeMaitre Vascular (LMAT) United States $0.596B 28.35
Surmodics (SRDX) United States $0.563B 81.90
Quanterix (QTRX) United States $0.518B 0.00
BioLife Solutions (BLFS) United States $0.364B 150.23
Vapotherm (VAPO) United States $0.335B 0.00
Rockwell Medical (RMTI) United States $0.331B 0.00
Insys Therapeutics (INSY) United States $0.328B 0.00
Utah Medical Products (UTMD) United States $0.300B 19.49
Owens & Minor (OMI) United States $0.271B 3.76
Bovie Medical (APYX) United States $0.260B 0.00
Cytosorbents (CTSO) United States $0.241B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.238B 0.00
Zynex (ZYXI) United States $0.145B 15.52
Fonar (FONR) United States $0.137B 7.33
Surface Oncology (SURF) United States $0.116B 0.00
Chimerix (CMRX) United States $0.102B 0.00
Female Health (VERU) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.096B 0.00
United-Guardian (UG) United States $0.087B 19.84
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.058B 17.14
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Valeritas Holdings (VLRX) United States $0.035B 0.00
Senestech (SNES) United States $0.029B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.008B 15.29